Reports

Drug name	NICE TAs	Comments
Gefitinib tablets	TA192 - Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer
Gemcitabine injection	TA116 - Gemcitabine for the treatment of metastatic breast cancer TA25 - Guidance on the use of gemcitabine for the treatment of pancreatic cancer TA285 - Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer TA476 - Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cance	Negative TA. Hospital use only.
Gemtuzumab ozogamicin	TA545 - Gemtuzumab ozogamicin for untreated acute myeloid leukaemia
Glatiramer acetate (Copaxone®)	TA527 - Beta interferons and glatiramer acetate for treating multiple sclerosis
Glatiramer injection	TA254 - Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis TA527 - Beta interferons and glatiramer acetate for treating multiple sclerosis
Gliteritinib	TA642 - Gilteritinib for treating relapsed or refractory acute myeloid leukaemia
Golimumab injection	TA233 - Golimumab for the treatment of ankylosing spondylitis TA220 - Golimumab for the treatment of psoriatic arthritis TA225 - Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs	Hospital use only
Guselkumab	TA711 - Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs
Hydrocortisone 0.5% cream	TA81 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
Hydrocortisone 0.5% ointment	TA81 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports